As a total outsider from bit-land at a day of talks on longevity science & venture, I’m struck by how much the long build–measure–learn cycles dictate strategies & tactics. And by how much leverage accrues by shortening those cycles!
Age 1 is thrilling. age1.com
Conversation
Did any methods for shortening build-measure-learn cycles stand out in particular?
1
Replying to
I was excited about the experimentation platform. And I liked Circumvent Pharma's approach of targeting an accelerated form of a broader range of neurodegenerative diseases as a test-bed. And of course, Age 1 itself pressures the culture to be more rapid.